Internal Medicine

Medicine & Life Sciences

1. Korea 100%
2. Registries 94%
3. Stents 86%
4. Myocardial Infarction 76%
5. Percutaneous Coronary Intervention 76%
6. Heart Failure 65%
7. Drug-Eluting Stents 60%
8. Multicenter Studies 51%
9. Fibrosis 50%
10. Type 2 Diabetes Mellitus 45%
11. Liver 44%
12. Portal Hypertension 43%
13. ST Elevation Myocardial Infarction 42%
14. Safety 40%
15. Confidence Intervals 39%
16. Mortality 39%
17. Therapeutics 38%
18. Liver Cirrhosis 36%
19. Venous Pressure 31%
20. zotarolimus 31%
21. Hemorrhage 29%
22. Sirolimus 29%
23. Mesenchymal Stem Cells 28%
24. Metabolic Syndrome 27%
25. Republic of Korea 27%
26. Diabetic Nephropathies 26%
27. Colonoscopy 26%
28. Serum 26%
29. Blood Pressure 25%
30. Odds Ratio 25%
31. Everolimus 25%
32. Prospective Studies 22%
33. Brain Natriuretic Peptide 21%
34. Amlodipine 21%
35. Colorectal Neoplasms 21%
36. Guidelines 20%
37. Stomach 20%
38. Incidence 20%
39. Chronic Hepatitis B 19%
40. Insulin Resistance 19%
41. Clopidogrel 18%
42. Acute Coronary Syndrome 18%
43. Placebos 18%
44. Paclitaxel 18%
45. Propensity Score 18%
46. Human Influenza 17%
47. Kidney 17%
48. Polyps 17%
49. Liver Diseases 17%
50. Thrombosis 17%
51. Randomized Controlled Trials 17%
52. Population 16%
53. Neoplasms 16%
54. Diabetes Mellitus 16%
55. Glucose 16%
56. Radial Artery 16%
57. Hypertension 16%
58. Podocytes 16%
59. Adiponectin 16%
60. Adenoma 15%
61. Cohort Studies 14%
62. Asthma 14%
63. Metformin 14%
64. Hepatocellular Carcinoma 14%
65. Non-alcoholic Fatty Liver Disease 14%
66. Obesity 13%
67. Aspirin 13%
68. Inbred OLETF Rats 13%
69. Stroke Volume 13%
70. Nutrition Surveys 13%
71. Angiotensin Receptor Antagonists 13%
72. Stomach Neoplasms 13%
73. fimasartan 12%
74. Alcoholic Liver Cirrhosis 12%
75. Non-ST Elevated Myocardial Infarction 12%
76. urushiol 11%
77. Multivariate Analysis 11%
78. Bacteremia 11%
79. Ultrasonography 11%
80. Essential Hypertension 11%
81. Sitagliptin Phosphate 11%
82. Losartan 11%
83. End Stage Liver Disease 11%
84. Elasticity Imaging Techniques 10%
85. 4-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(tert-butoxymethyl)piperazin-2-one 10%
86. Insulin 10%
87. C-Reactive Protein 10%
88. Rhus 10%
89. Systolic Heart Failure 10%
90. Infections 10%
91. Coronary Angiography 10%
92. Hepatitis 10%
93. Survival 10%
94. Portal Pressure 10%
95. Fasting 10%
96. Signet Ring Cell Carcinoma 10%
97. Chronic Disease 10%
98. Meta-Analysis 10%
99. High Fat Diet 9%
100. Blood Platelets 9%